Drug intelligence / Profile preview

nitrous oxide + saline

Development stage
Unknown
Lead developer
Women's College Hospital
Modality
Small Molecules
Administration
Inhalation, Intravenous
01

Overview

Nitrous oxide (N2O), commonly known as laughing gas, is an inhalational anesthetic being investigated as a rapid-acting treatment for treatment-resistant depression (TRD). In the SMILE (Sustained Mood Improvement with Laughing Gas Exposure) trial led by Women's College Hospital, it is administered at a 50% concentration for one hour in combination with intravenous saline. Nitrous oxide acts primarily as an N-methyl-D-aspartate (NMDA) receptor antagonist, a mechanism shared with ketamine, which is thought to modulate glutamatergic neurotransmission to alleviate depressive symptoms. This specific combination and protocol are being evaluated for their ability to provide sustained mood improvement in patients who have failed multiple standard antidepressant therapies.

Other names
laughing gasN2ON-2ON 2Onitrous oxide
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)AMPAR (AMPA receptor)

Beyond the preview

Go deeper on nitrous oxide + saline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nitrous oxide + saline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call